Yile Chen

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Acea Therapeutics, Inc., Hangzhou Acea Pharmaceutical Research Co., Ltd., Zhejiang Acea Pharmaceuticals Co., Ltd.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yile Chen. Retrieved from https://idiyas.com/inventor/yile-chen-llh3q2cj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 12.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Zhejiang, CN (2020)
Hangzhou, CN (2022)

Company Filing History:

3 out of 10

Acea Therapeutics, Inc.

patents

1 out of 1

Hangzhou Acea Pharmaceutical Research Co., Ltd.

patent

1 out of 1

Zhejiang Acea Pharmaceuticals Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358895 - Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereof (2025-07-15),

2. 11498922 - Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide (2022-11-15),

3. 10533011 - Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same (2020-01-14),

Title: Yile Chen: Innovator in Pharmaceutical Chemistry

Introduction

Yile Chen is a prominent inventor based in Zhejiang, China, known for his contributions to pharmaceutical chemistry. He holds a total of 3 patents that focus on innovative processes and formulations for treating various medical conditions. His work has significant implications for the treatment of proliferation and immunological disorders.

Latest Patents

Yile Chen's latest patents include a process for the manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide. This invention relates to solid forms of certain N-(pyrimidinyloxy)acrylamide derivatives that are useful in treating proliferation disorders and diseases related to the dysregulation of kinases, including EGFR and others. The invention provides methods for making these materials, their salts, polymorphs, and pharmaceutical compositions that can treat conditions such as tumors, inflammatory diseases, and autoimmune disorders. Another significant patent involves a pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide. This invention also focuses on methods of making certain pyrrolopyrimidine derivatives useful in treating similar medical conditions.

Career Highlights

Throughout his career, Yile Chen has worked with notable companies in the pharmaceutical sector, including Acea Therapeutics, Inc. and Hangzhou Acea Pharmaceutical Research Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug formulation and manufacturing.

Collaborations

Yile Chen has collaborated with several professionals in his field, including Long Mao and Jia Liu. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yile Chen's work in pharmaceutical chemistry exemplifies the impact of innovation on medical treatment. His patents reflect a commitment to addressing complex health issues through scientific advancement.

Profile summary based on public USPTO records.